IB20 PCSK9 antagonists
PK200900088A0Undetermined Publication Date: 2009-02-10MERCK & CO INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200900088
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2009-01-30
- Publication Date
- 2009-02-10
Abstract
Antagonist of human proprotein convertase subtilisin-kexin type 9 ("PCSK9") comprising a heavy chain variable region comprising a CDR3 domain comprising SEQ ID NO: 17 or an equivalent thereof, and / or a light chain variable region comprising a CDR3 domain comprising SEQ ID NO: 7 or an equivalent thereof, is disclosed. The disclosed antagonist is effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonist for use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonist, vector, host cell, and composition comprising the antagonist. Method of making PCSK9-specific antagonist as well as applications of the antagonist for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure.
Need to check novelty before this filing date? Find Prior Art
